RxDoctor Payments Data

Sandeep Joshi, MD

Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1730158817

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,653 of the $8,834 with a category attached, or 86.6%. 19 manufacturers reported payments, led by Medtronic at 29.3% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IN, where the typical reported total is $13,586.

$8,834in general payments, 2019–2025

Across 109 payments — averaging $81.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Abbott$2K
  • Biosense Webster, Inc.$1K
  • Boston Scientific$1K
  • Medical Device Business Services, Inc.$741
  • Impulse Dynamics (USA) Inc.$183
  • plus $807 from 13 others

What the payments were for

  • Travel & lodging$1,18113%
  • Food & beverage$7,65387%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,834 in reported general payments places this provider in the 35th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$167,134
Medicare patients
535
Services billed
3,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban294$341,652
XareltoRivaroxaban75$71,391
Dofetilide70$15,329
Amiodarone Hcl118$4,412
Mexiletine Hcl30$3,375
Flecainide Acetate42$2,438
Diltiazem 24hr Er (Cd)Diltiazem Hcl40$2,407
Metoprolol Succinate195$2,005
SotalolSotalol Hcl76$1,467
Nebivolol Hcl15$794
Propafenone Hcl11$631
Digoxin15$574
Valsartan20$442
Atorvastatin Calcium44$429
Potassium Chloride17$424

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$341,652294 claims
Johnson & JohnsonXarelto$43$71,39175 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

Other clinical cardiac electrophysiology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →